• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions.Par14 蛋白与胰岛素受体底物 1(IRS-1)结合,从而增强胰岛素诱导的 IRS-1 磷酸化和代谢作用。
J Biol Chem. 2013 Jul 12;288(28):20692-701. doi: 10.1074/jbc.M113.485730. Epub 2013 May 29.
2
Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.肽基脯氨酰顺/反异构酶 NIMA 相互作用蛋白 1 与胰岛素受体底物-1 结合,增强胰岛素作用和脂肪生成。
J Biol Chem. 2011 Jun 10;286(23):20812-22. doi: 10.1074/jbc.M110.206904. Epub 2011 Mar 17.
3
The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.脯氨酰异构酶Pin1与核糖体蛋白S6激酶相互作用,以增强胰岛素诱导的AP-1活性和细胞转化。
Carcinogenesis. 2009 Apr;30(4):671-81. doi: 10.1093/carcin/bgp027. Epub 2009 Jan 23.
4
Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the γ subunit.脯氨酰异构酶Pin1通过与γ亚基中的CBS结构域结合来负向调节AMP激活的蛋白激酶(AMPK)。
J Biol Chem. 2015 Oct 2;290(40):24255-66. doi: 10.1074/jbc.M115.658559. Epub 2015 Aug 14.
5
Prolyl isomerase Pin1 regulates mouse embryonic fibroblast differentiation into adipose cells.脯氨酰异构酶 Pin1 调控小鼠胚胎成纤维细胞向脂肪细胞分化。
PLoS One. 2012;7(3):e31823. doi: 10.1371/journal.pone.0031823. Epub 2012 Mar 7.
6
p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance.p38 丝裂原活化蛋白激酶依赖性表皮生长因子受体家族的转激活:应激诱导 IRS-1 丝氨酸磷酸化和胰岛素抵抗的一种新的共同机制。
Diabetes. 2011 Apr;60(4):1134-45. doi: 10.2337/db09-1323. Epub 2011 Mar 8.
7
Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.脯氨酰异构酶 Pin1 对心肌肥厚信号的调节。
Circ Res. 2013 Apr 26;112(9):1244-52. doi: 10.1161/CIRCRESAHA.113.301084. Epub 2013 Mar 13.
8
Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?Pin1 调节与生理状态和神经退行性变。对 3 型糖尿病发病机制有何贡献?
Int J Mol Sci. 2018 Aug 8;19(8):2319. doi: 10.3390/ijms19082319.
9
Parvulin (Par14), a peptidyl-prolyl cis-trans isomerase, is a novel rRNA processing factor that evolved in the metazoan lineage.Parvulin(Par14)是一种肽基脯氨酰顺反异构酶,是后生动物谱系中进化而来的一种新型核糖体RNA加工因子。
Mol Cell Proteomics. 2009 Jul;8(7):1552-65. doi: 10.1074/mcp.M900147-MCP200. Epub 2009 Apr 14.
10
Human DNA-binding peptidyl-prolyl cis/trans isomerase Par14 is cell cycle dependently expressed and associates with chromatin in vivo.人类DNA结合肽基脯氨酰顺/反异构酶Par14在细胞周期中呈依赖性表达,并在体内与染色质相关联。
BMC Biochem. 2015 Feb 3;16:4. doi: 10.1186/s12858-015-0033-x.

引用本文的文献

1
The Actin-Binding Prolyl-Isomerase Par17 Sustains Its Substrate Selectivity by Interdomain Allostery.肌动蛋白结合脯氨酰异构酶Par17通过结构域间变构作用维持其底物选择性。
Proteins. 2025 Sep;93(9):1481-1497. doi: 10.1002/prot.26807. Epub 2025 Mar 12.
2
PPIases Par14/Par17 Affect HBV Replication in Multiple Ways.PPIases Par14/Par17 通过多种方式影响 HBV 复制。
Viruses. 2023 Feb 6;15(2):457. doi: 10.3390/v15020457.
3
Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation.Par14 与雄激素受体相互作用,增强其转录活性和前列腺癌增殖。
Cancer Med. 2023 Apr;12(7):8464-8475. doi: 10.1002/cam4.5587. Epub 2022 Dec 30.
4
Circulating levels of PIN1 and glucose metabolism in young people with obesity.肥胖青少年中 PIN1 和葡萄糖代谢的循环水平。
J Endocrinol Invest. 2022 Sep;45(9):1741-1748. doi: 10.1007/s40618-022-01812-8. Epub 2022 May 18.
5
Design and Synthesis of Oligopeptidic Parvulin Inhibitors.寡肽帕夫林抑制剂的设计与合成。
ChemMedChem. 2022 Jun 3;17(11):e202200050. doi: 10.1002/cmdc.202200050. Epub 2022 Apr 26.
6
Oncogenic Hijacking of the PIN1 Signaling Network.PIN1信号网络的致癌性劫持
Front Oncol. 2019 Feb 25;9:94. doi: 10.3389/fonc.2019.00094. eCollection 2019.
7
Structural Analysis of the 42 kDa Parvulin of . parvulin 的 42kDa 结构分析
Biomolecules. 2019 Mar 7;9(3):93. doi: 10.3390/biom9030093.
8
Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?Pin1 调节与生理状态和神经退行性变。对 3 型糖尿病发病机制有何贡献?
Int J Mol Sci. 2018 Aug 8;19(8):2319. doi: 10.3390/ijms19082319.
9
Egg white hydrolysate shows insulin mimetic and sensitizing effects in 3T3-F442A pre-adipocytes.蛋清水解物在3T3-F442A前脂肪细胞中显示出胰岛素模拟和增敏作用。
PLoS One. 2017 Oct 3;12(10):e0185653. doi: 10.1371/journal.pone.0185653. eCollection 2017.
10
NmPin from the marine thaumarchaeote Nitrosopumilus maritimus is an active membrane associated prolyl isomerase.来自海洋奇古菌嗜盐硝化球菌的NmPin是一种与膜相关的活性脯氨酰异构酶。
BMC Biol. 2016 Jun 27;14:53. doi: 10.1186/s12915-016-0274-1.

本文引用的文献

1
Inflammation and lipid signaling in the etiology of insulin resistance.炎症和脂质信号在胰岛素抵抗的发病机制中的作用。
Cell Metab. 2012 May 2;15(5):635-45. doi: 10.1016/j.cmet.2012.04.001.
2
Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease.脯氨酸异构特异性抗体揭示了阿尔茨海默病中早期致病性 tau 构象。
Cell. 2012 Mar 30;149(1):232-44. doi: 10.1016/j.cell.2012.02.016.
3
Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity.脯氨酰异构酶 Pin1 在 Toll 样受体信号转导和 I 型干扰素介导的免疫中的重要作用。
Nat Immunol. 2011 Jul 10;12(8):733-41. doi: 10.1038/ni.2069.
4
Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.肽基脯氨酰顺/反异构酶 NIMA 相互作用蛋白 1 与胰岛素受体底物-1 结合,增强胰岛素作用和脂肪生成。
J Biol Chem. 2011 Jun 10;286(23):20812-22. doi: 10.1074/jbc.M110.206904. Epub 2011 Mar 17.
5
Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats.体育锻炼可降低循环脂多糖和 TLR4 激活,并改善 DIO 大鼠组织中的胰岛素信号转导。
Diabetes. 2011 Mar;60(3):784-96. doi: 10.2337/db09-1907. Epub 2011 Jan 31.
6
Pin1 associates with and induces translocation of CRTC2 to the cytosol, thereby suppressing cAMP-responsive element transcriptional activity.Pin1 与 CRTC2 结合并诱导其向细胞质易位,从而抑制 cAMP 反应元件转录活性。
J Biol Chem. 2010 Oct 22;285(43):33018-33027. doi: 10.1074/jbc.M110.137836. Epub 2010 Jul 30.
7
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.脯氨酰异构酶PIN1:磷酸化信号传导与疾病中的关键新转折
Nat Rev Mol Cell Biol. 2007 Nov;8(11):904-16. doi: 10.1038/nrm2261.
8
Prolyl cis-trans isomerization as a molecular timer.脯氨酰顺反异构化作为一种分子计时器。
Nat Chem Biol. 2007 Oct;3(10):619-29. doi: 10.1038/nchembio.2007.35.
9
Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling.人胰岛素受体底物-1在丝氨酸629处的磷酸化在胰岛素信号传导中起积极作用。
Endocrinology. 2007 Oct;148(10):4895-905. doi: 10.1210/en.2007-0049. Epub 2007 Jul 19.
10
Peptidyl-prolyl isomerase inhibitors.肽基脯氨酰异构酶抑制剂
Biopolymers. 2006;84(2):125-46. doi: 10.1002/bip.20240.

Par14 蛋白与胰岛素受体底物 1(IRS-1)结合,从而增强胰岛素诱导的 IRS-1 磷酸化和代谢作用。

Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions.

机构信息

Department of Medical Science, Graduate School of Medicine, University of Hiroshima, 1-2-3 Kasumi, Minami-ku, 734-8553 Hiroshima City, 734-8553 Hiroshima, Japan.

出版信息

J Biol Chem. 2013 Jul 12;288(28):20692-701. doi: 10.1074/jbc.M113.485730. Epub 2013 May 29.

DOI:10.1074/jbc.M113.485730
PMID:23720771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3711332/
Abstract

Pin1 and Par14 are parvulin-type peptidyl-prolyl cis/trans isomerases. Although numerous proteins have been identified as Pin1 substrates, the target proteins of Par14 remain largely unknown. Par14 expression levels are increased in the livers and embryonic fibroblasts of Pin1 KO mice, suggesting a compensatory relationship between the functions of Pin1 and Par14. In this study, the association of Par14 with insulin receptor substrate 1 (IRS-1) was demonstrated in HepG2 cells overexpressing both as well as endogenously in the mouse liver. The analysis using deletion-mutated Par14 and IRS-1 constructs revealed the N-terminal portion containing the basic domain of Par14 and the two relatively C-terminal portions of IRS-1 to be involved in these associations, in contrast to the WW domain of Pin1 and the SAIN domain of IRS-1. Par14 overexpression in HepG2 markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events, PI3K binding with IRS-1 and Akt phosphorylation. In contrast, treating HepG2 cells with Par14 siRNA suppressed these events. In addition, overexpression of Par14 in the insulin-resistant ob/ob mouse liver by adenoviral transfer significantly improved hyperglycemia with normalization of hepatic PEPCK and G6Pase mRNA levels, and gene suppression of Par14 using shRNA adenovirus significantly exacerbated the glucose intolerance in Pin1 KO mice. Therefore, although Pin1 and Par14 associate with different portions of IRS-1, the prolyl cis/trans isomerization in multiple sites of IRS-1 by these isomerases appears to be critical for efficient insulin receptor-induced IRS-1 phosphorylation. This process is likely to be one of the major mechanisms regulating insulin sensitivity and also constitutes a potential therapeutic target for novel insulin-sensitizing agents.

摘要

Pin1 和 Par14 是 parvulin 型肽基脯氨酰顺/反式异构酶。虽然已经鉴定出许多蛋白质是 Pin1 的底物,但 Par14 的靶蛋白仍知之甚少。Pin1 KO 小鼠的肝脏和胚胎成纤维细胞中 Par14 的表达水平增加,表明 Pin1 和 Par14 功能之间存在代偿关系。在本研究中,在过表达这两种蛋白的 HepG2 细胞以及内源性表达于小鼠肝脏中,证明了 Par14 与胰岛素受体底物 1(IRS-1)之间的关联。使用缺失突变 Par14 和 IRS-1 构建体的分析表明,Par14 的 N 端包含碱性结构域,IRS-1 的两个相对 C 端部分参与了这些相互作用,而 Pin1 的 WW 结构域和 IRS-1 的 SAIN 结构域则不参与。Par14 在 HepG2 中的过表达显著增强了胰岛素诱导的 IRS-1 磷酸化及其下游事件,即 PI3K 与 IRS-1 的结合和 Akt 的磷酸化。相反,用 Par14 siRNA 处理 HepG2 细胞抑制了这些事件。此外,通过腺病毒转染在胰岛素抵抗的 ob/ob 小鼠肝脏中过表达 Par14,可显著改善高血糖,使肝 PEPCK 和 G6Pase mRNA 水平正常化,并用 shRNA 腺病毒抑制 Par14 的基因表达可显著加重 Pin1 KO 小鼠的葡萄糖不耐受。因此,尽管 Pin1 和 Par14 与 IRS-1 的不同部分结合,但这些异构酶在 IRS-1 的多个部位进行脯氨酰顺/反式异构化似乎对有效的胰岛素受体诱导的 IRS-1 磷酸化至关重要。这一过程可能是调节胰岛素敏感性的主要机制之一,也是新型胰岛素增敏剂的潜在治疗靶点。